SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Hormone Boost Lets Mice Live Longer Without Fasting, University of Texas Southwestern Medical Center Study
October 24, 2012
 · 
1 min read
Lone Star Bio
Cell Mechanism Findings Could One Day be Used to Engineer Organs, University of Texas Study
October 22, 2012
 · 
1 min read
Lone Star Bio
Are Knee Injuries Tied to Menstrual Cycle? University of Texas Study
October 22, 2012
 · 
1 min read
Lone Star Bio
Abstinence, Having Sex Late Leads to True Love, University of Texas Study
October 18, 2012
 · 
1 min read
Lone Star Bio
Depression and Shortened Telomeres Increased Bladder Cancer Mortality, University of Texas MD Anderson Cancer Center Study
October 18, 2012
 · 
1 min read
Lone Star Bio
Longer Baby’s on Formula, Higher the Leukemia Risk, University of Texas Study
October 18, 2012
 · 
1 min read
Lone Star Bio
“Nano-Pancake” Sensor Warns With Color, Rice University Study
October 11, 2012
 · 
1 min read
Lone Star Bio
Drug “May Prevent Stroke Damage,” Lancet Neurology Reveals
October 8, 2012
 · 
1 min read
Lone Star Bio
Fear Relapse: Why Phobias are Hard to Cure, Texas A&M University Study
October 3, 2012
 · 
1 min read
Lone Star Bio
Weedkiller Tied to Birth Defect, Baylor College of Medicine Study
October 1, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Load More